Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.80 +0.45 (+2.93%)
As of: Sep 30, 2026 · 12:12 PM EDT

Ascentage Pharma Group International (AAPG) Receivables (2023 - 2026)

Updated

Ascentage Pharma Group International (AAPG) posted Receivables of $23.05 million for Q2 2026, up 112.8% from $10.83 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Receivables (2023 - 2026) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International's Receivables came in at $35.4 million, up 189.4% from FY2024.

  • In prior years, Ascentage Pharma Group International's Receivables was $12.23 million in FY2024 (-43.3%) and $21.58 million in FY2023.
  • Quarterly Receivables has run from a low of $10.83 million in Q2 2025 to a high of $35.87 million in Q4 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 19.05 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 13.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.68 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.13 Bn
10 Ascentage Pharma Group International 1.45 Bn 419.76 Mn - 23.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.05 Mn
Dec 31, 2025 35.87 Mn
Jun 30, 2025 10.83 Mn
Dec 31, 2024 12.43 Mn
Dec 31, 2023 21.18 Mn
API Access

Ascentage Pharma Group International Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=AAPG&period=max&api_key=YOUR_API_KEY